Back
AB

Alamar Biosciences,

ALMR

Other · NASDAQ · IPO April 17, 2026

Other
Website unavailable

01

Company Overview

Alamar Biosciences, is filing to list on NASDAQ Global Select. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.

Alamar Biosciences, is going public on NASDAQ Global Select on 2026-04-17. Offering 11,250,000 shares.

Recent headlines

via web search

02

AI Analysis

Possible growth narrative

Sits adjacent to Other — themes that are currently drawing meaningful capital and attention.

Risks

Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.

Volatility

Expect elevated price volatility in the first weeks of trading as supply and demand find balance.

Market attention

Recently listed — monitoring early trading activity and analyst initiations.

Educational summary only. Not investment advice.

03

Related Themes

Other

04

IPO Information

IPO date
April 17, 2026
Exchange
NASDAQ
Status
Recently Listed
Industry
Other
Valuation
$191.3M raise
Headquarters
Attention score
61 / 100
Ticker
ALMR